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Purpose: Procalcitonin (PCT) is a current, frequently used marker for severe bacte-
rial infection. The aim of this study was to assess the ability of PCT levels to differ-
entiate bacteremic from nonbacteremic patients with fever. We assessed whether 
PCT level could be used to accurately rule out a diagnosis of bacteremia. Materials 
and Methods: Serum samples and blood culture were obtained from patients with 
fever between August 2008 and April 2009. PCT was analyzed using a VIDAS® 
B.R.A.H.M.S PCT assay. We reviewed the final diagnosis and patient histories, in-
cluding clinical presentation and antibiotic treatment. Results: A total of 300 patients 
with fevers were enrolled in this study: 58 with bacteremia (positive blood culture) 
(group I); 137 with local infection (group II); 90 with other diseases (group III); and 
15 with fevers of unknown origin (group IV). PCT levels were significantly higher 
in patients with bacteremia than in those with non-bacteremia (11.9 ± 25.1 and 2.5 ± 
14.7 ng/mL, respectively, p < 0.001). The sensitivity and specificity were 74.2% and 
70.1%, respectively, at a cut-off value of 0.5 ng/mL. A serum PCT level of < 0.4 ng/
mL accurately rules out diagnosis of bacteremia. Conclusion: In febrile patients, ele-
vated PCT may help predict bacteremia; furthermore, low PCT levels were helpful 
for ruling out bacteremia as a diagnosis. Therefore, PCT assessment could help phy-
sicians limit the number of prescriptions for antibiotics. 
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INTRODUCTION
The prompt diagnosis and treatment with an appropriate antimicrobial agent is im-
portant in reducing morbidity and mortality associated with bacteremia.1 Microbi-
ologic culturing requires at least 24-48 hours, and negative cultures do not exclude 
the presence of infection.2 Moreover, only 5-10% of blood cultures performed in 
hospitals show microorganisms.3 Thus, a rapid and reliable test to rule out bactere-
mia would be helpful in decision making. Procalcitonin (PCT), the precursor of 
the hormone calcitonin, is produced by C-cells of the thyroid gland or neuroendo-
crine cells in the lung or intestine.4,5 Although only very few PCT molecules are 
released into circulation in a normal state, serum PCT concentrations increase in 
patients with bacterial and viral infections; systemic bacterial infection, especially, Procalcitonin for Early Diagnosis of Bacteremia
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Anaerobic/F (prereduced enriched soybean-casein digest 
broth) or Peds Plus F (enriched soybean-casein digest broth), 
and bacterial growth was monitored. From the positive sam-
ples a small volume was inoculated onto blood agar and 
MacConkey agar plates and incubated overnight at 37°C. 
MicroScan WalkAway-96 System (Dade Behring, Sacra-
mento, CA, USA) was used to identify the bacteria species. 
If a single blood culture yielded coagulase-negative staphy-
lococci (CNS), viridans streptococci, Bacillus spp., Coryne-
bacterium spp. or Propionibacterium spp., the culture was 
considered to have been contaminated. 
The comparison of group differences for continuous vari-
ables was performed using one-way ANOVA. Receiver op-
erating characteristic (ROC) curves were plotted for PCT 
and CRP, and diagnostic accuracy was assessed by calculat-
ing the areas under the ROC curves (AUCs). Because we 
wanted to evaluate the capacity of PCT to rule out the diag-
nosis of bacteremia, we sorted the values of PCT into ten 
deciles and calculated sensitivity, specificity, positive pre-
dictive value (PPV) and negative predictive value (NPV) 
associated with the nine cut-off values separating the ten 
deciles. All statistical analyses were performed using SPSS 
ver. 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Of 300 patients enrolled in the study, 23 were excluded be-
cause they were diagnosed as having disorders that were 
not suspected to be infection: trauma, hemorrhage, burns, 
or immunologic disease. Twenty-five positive blood cul-
tures were excluded because they were considered to have 
been contaminated; 23 coagulase negative streptococci in 
single blood culture and 2 Bacillus spp.. None of the re-
maining 252 patients were enrolled more than once, and all 
were classified as either bacteremia (group I, n = 31), local-
ized infection (group II, n = 129), other disorders (group III, 
n = 83), or FUO (group IV, n = 9)(Table 1). Thirty-one pa-
tients in the bacteremic group had 16 Gram-negative bacilli 
(Escherichia coli in nine cases; Klebsiella pneumoniae in 
five; Serratia marcescens in one; Salmonella Typhi in one), 
seven glucose non-fermenting gram-negative bacilli (Aci-
netobacter baumannii in three cases; Pseudomonas aerugi-
nosa in two, Acinetobacter lwoffii in two), six gram-positive 
cocci (Staphylococcus aureus in four cases; Streptococcus 
mitis in one; Enterococcus casseliflavus in one), and two 
cases of Candida tropicalis (Table 2). The PCT levels in 
can induce higher concentrations of serum PCT.6 PCT con-
centration has been reported to be useful for the early diagno-
sis of bacteremia and decisive initial antimicrobial therapy.7-11 
Furthermore, following administration of antimicrobial 
agents with serial measurements of PCT levels can help to 
protect against emerging antimicrobial-resistant strains by re-
stricting unnecessary antibiotic use.12 A new automated rapid 
quantitative assay, VIDAS® B.R.A.H.M.S PCT assay (bio-
Mérieux, Marcy LʼEtoile, France), is based on an enzyme-
linked fluorescent immunoassay (ELFA) and has a func-
tional sensitivity of 0.09 ng/mL. 
The aim of this study was to assess the ability of PCT 
level to differentiate bacteremia from non-bacteremia in pa-
tients with fever using this new assay. We also assessed 
whether PCT level could be used to rule out the diagnosis 
of bacteremia.
MATERIALS AND METHODS
This study was carried out from August 2008 to April 2009 
at a tertiary hospital in Korea. All 300 patients with acute 
fever (temperature ≥ 38°C) were enrolled in this study, and 
blood cultures were performed for all of them. These patients 
were not administered antimicrobial agents prior to blood 
culture. Their medical records were reviewed for clinical 
diagnosis, laboratory findings, and antimicrobial treatments. 
The patients were classified as bacteremia (group I), local-
ized infection (group II), other disorders (group III), and fe-
ver of unknown origin (FUO, group IV) according to the fi-
nal diagnosis. 
Blood samples were obtained from each patient to deter-
mine serum PCT level and C-reactive protein (CRP) level 
at the same time that the samples were obtained for culture. 
PCT level was measured via an automatic analyzer, the VI-
DAS® B.R.A.H.M.S PCT assay (bioMérieux, Marcy 
L’Etoile, France). The lower limit of detection of the assay 
was 0.05 ng/mL. CRP level was measured using CRPα 
Auto (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 
by TBA-200 FR NEO (Toshiba Medical Systems Corpora-
tion, Tochigi-ken, Japan). Blood cultures were processed in 
more than two pairs of bottles and were incubated in aero-
bic and anaerobic conditions in an automatic analyzer, 
BACTEC 9240 Blood Culture System (Becton Dickinson 
Diagnostic Instrument Systems, Sparks, MD, USA). Blood 
samples were secured in Bactec culture vial types Plus Aer-
obic/F (enriched soybean-casein digest broth), Bactec Plus Myeong Hee Kim, et al.
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cant difference was found between PCT levels in the bacte-
remic group (group I) and in the localized infection group 
(group II), which was 1.2 ± 3.5 ng/mL (p < 0.001). There 
were no significant differences between the bacteremic group 
and the non-bacteremic groups (group II, III, and IV) with 
respect to CRP levels (p = 0.298). 
The PCT levels between the sites of localized infections 
were not significantly different, but the CRP levels showed 
significant differences (Table 3). The infection sites of pa-
tients with localized infection were the upper respiratory 
gram-positive and gram-negative bacteremia were 26.26 
ng/mL (0.22-125.38 ng/mL) and 7.95 ng/mL (< 0.05-47.97 
ng/mL), respectively, with the levels significantly higher in 
gram-positive (p = 0.009). However, CRP levels were not 
significantly different between two types of bacteremia (p = 
0.659). 
The mean serum PCT level was 11.9 ± 25.1 ng/mL in the 
bacteremic group (group I), which was significantly higher, 
than in the non-bacteremic groups (groups II, III, and IV), 
which was 2.5 ± 14.7 ng/mL (p < 0.001). The most signifi-
Table 1. Patient Characteristics According to Group
Group I Group II Group III Group IV
Number 31 129 83 9
Sex (M : F) 16 : 15 66 : 63 57 : 26 5 : 4
Age 62.1 ± 19.3 20.9 ± 28.4 52.6 ± 22.3 19.9 ± 19.2
Procalcitonin 11.9 ± 25.2 1.2 ± 3.5   4.7 ± 23.5 0.2 ± 0.1
C-reactive protein 13.6 ± 9.1 6.6 ± 7.8 10.2 ± 8.5 5.1 ± 4.6
Table 2. PCT and CRP Concentrations According to Pathogen in Patients with Bacteremia
Pathogen  Number of patients PCT (ng/mL) CRP (mg/dL)
Gram-positive cocci   6   26.26 (0.22 - 125.38)   16.18 (5.0 - 31.5)
    Staphylococcus aureus   4 63.93 (0.5 - 125.38)     21.38 (14.6 - 31.5)
    Streptococcus mitis   1 21.11   5.0
    Enterococcus casseliflavus   1   0.22   6.6
Gram-negative bacilli 23      7.95 (< 0.05 - 47.97)     12.53 (< 0.5 - 27.7)
    Escherichia coli   9 12.34 (0.06 - 47.97)       11.62 (< 0.5 - 26.10)
    Klebsiella pneumoniae   5 11.65 (0.16 - 44.27)       13.6 (8.10 - 22.50)
    Serratia marcescens   1   2.17 20.2
    Salmonella typhi   1   0.12 12.1
    Acinetobacter baumannii    3    0.64 (< 0.05 - 1.32)      11.8 (< 0.5 - 27.7)
    Pseudomonas aeruginosa   2 4.15 (0.54 - 7.76)   6.3 (6.0 - 6.6)
    Acinetobacter lwoffii   2 0.47 (0.07 - 0.87)     17.7 (14.8 - 20.6)
Candida tropicalis   2   15.12 (12.51 - 17.73) 18.65 (7.3 - 30.0)
PCT, procalcitonin; CRP, C-reactive protein.
Table 3. PCT and CRP Concentrations (Mean ± SD) on the Infected Site in Patients with Localized Infection
Number of patients PCT (ng/mL) CRP (mg/dL)
Upper respiratory infection 31 0.35 ± 0.53 3.45 ± 6.52
Lower respiratory infection 46 1.29 ± 4.43 5.70 ± 6.45
Urinary infection 27 2.04 ± 4.05 9.44 ± 9.33
Gastrointestinal infection 11 0.78 ± 1.79 4.18 ± 7.04
Skin infection   7 2.34 ± 5.19 14.16 ± 6.46
Osteoarticular infection   3 0.33 ± 0.25 20.5 ± 0.89
Otitis media   2 0.28 ± 0.28 4.95 ± 0.35
Infective endocarditis   1 0.05  0.70
Malaria    1 1.36  6.20
 p value*   0.797 < 0.001
PCT, procalcitonin; CRP, C-reactive protein.
*Significance between sites of localized infections. Procalcitonin for Early Diagnosis of Bacteremia
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of 0.4 ng/mL. Sensitivity, specificity, PPV and NPV at the 
cut-off value 0.5 ng/mL, which was recommended by the 
manufacturer, were 74.2%, 70.1%, 26.1% and 95.1%, re-
spectively. 
DISCUSSION
Early diagnosis of bacteremia in patients with fever is im-
portant for reducing the morbidity and mortality associated 
with bacteremia and its complications.1 The gold standard 
for diagnosis of bacteremia is isolation and identification of 
organisms; however, blood cultures lack sensitivity, are 
time consuming, and can be problematic due to skin micro-
organism contamination.13 The diagnosis of bacteremia in 
tract in 31 cases; the lower respiratory tract in 46 cases; the 
urinary tract in 27 cases; the gastrointestinal tract in 11 cas-
es; the skin infectionin 7 cases; osteoarticular infection in 3 
cases; otitis media in two cases; infective endocarditis in 
one case; and malaria in one case. 
Fig. 1 presents the ROC curves of the PCT and CRP con-
centrations for discrimination between patients in the bacte-
remic group (group I) and patients in the non-bacteremic 
groups (groups II, III, and IV). The AUCs were 0.753 and 
0.696, respectively. The AUCs for discrimination of bacte-
remia from localized infection were 0.761 and 0.739, re-
spectively (Fig. 1). 
Sensitivity, specificity, PPV and NPV of PCT levels for 
the nine cut-off values are shown in Table 4. The highest 
NPV was 95.4%, which was associated with a cut-off value 
Table 4. Diagnostic Performances of Serum PCT Assessment for the Nine Cut-Off Values That Separate the 
Ten Deciles of PCT Distribution
Cut-off value 
(ng/mL)
No. of cases under the 
cut-off value (%)
Sensitivity (%) Specificity (%)
Positive predictive 
value (%)
Negative predictive 
value (%)
< 0.05   37 (14.7) 96.8 15.0 14.0 97.3
   0.07   59 (23.4) 93.5 20.5 14.5 94.9
   0.10   79 (31.3) 90.3 32.3 16.2 96.2
   0.16 104 (41.3) 87.1 44.9 17.6 95.2
   0.23 128 (50.8) 77.4 55.9 20.2 95.3
   0.40 152 (60.3) 74.2 66.1 24.0 95.4
   0.63 177 (70.2) 61.3 75.6 25.3 93.2
   1.37 202 (80.2) 48.4 83.5 32.0 92.6
   5.98 227 (90.1) 35.5 94.5 48.0 91.6
PCT, procalcitonin.
Fig. 1. (A) Receiver operator characteristic curve demonstrating sensitivity as a function of one-specificity for discriminating patients with 
blood culture positivity based on procalcitonin (PCT) and C-reactive protein (CRP) levels. PCT and CRP had areas under the receiver oper-
ator characteristic curve of 0.753 and 0.696, respectively. (B) Receiver operator characteristic curve demonstrating sensitivity as a func-
tion of one-specificity for discriminating patients with bacteremia from patients with localized infection based on PCT and CRP. PCT and 
CRP had areas under the receiver operator characteristic curve of 0.769 and 0.746, respectively.
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study, there was no significant difference between mean 
CRP concentrations of patients with bacteremia and non-
bacteremia. ROC analysis confirmed that the diagnostic 
utility of CRP was inferior to that of PCT in discriminating 
between these conditions. 
We found that a PCT value of < 0.4 ng/mL could rule out 
bacteremia with a high degree of accuracy, because the 
NPV associated with this threshold was as high as 95.4%. 
Similarly, a previous study reported that < 0.4 ng/mL was 
the best cut-off value for ruling out bacteremia.12 Determi-
nation of the PCT level seems to be a consistent tool for 
ruling out bacteremia in patients with acute fever. 
In conclusion, PCT level could be a reliable marker to 
rule out or predict bacteremia in patients presenting with 
acute fever, and therefore, help in deciding the appropriate 
use of antimicrobial agents. More prospective and large-
scale studies are needed to better define the usefulness of 
PCT levels in various clinical settings. 
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